Inhibition of recombinant low-voltage-activated Ca2+ channels by the neuroprotective agent BW619C89 (Sipatrigine)

Neuropharmacology

Volumn 39, Issue 7, 2000, Pages 1247-1253

  McNaughton, N C L ^a   Hainsworth, A H ^b   Green, P J ^a   Randall, A D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Anticonvulsant; Calcium channels; Lamotrigine; Neuroprotection; T type

Indexed keywords

CALCIUM CHANNEL; MIBEFRADIL; SIPATRIGINE; SODIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL MEMBRANE DEPOLARIZATION; CONCENTRATION RESPONSE; DRUG EFFECT; HUMAN; KINETICS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELL LINE; ELECTROPHYSIOLOGY; HUMANS; KIDNEY; MEMBRANE POTENTIALS; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; PIPERAZINES; PYRIMIDINES; RATS; RECOMBINANT PROTEINS; SODIUM CHANNELS;

EID: 0034117401     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00201-4     Document Type: Article

References (29)

1. Bal T., McCormick D.A. Mechanisms of oscillatory activity in guinea pig nucleus reticularis thalami in vitro: a mammalian pacemaker. Journal of Physiology. 468:1993;669-691.
2. Coulter D.A. Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in? Journal of Child Neurology. 12:1997;S2-9.
3. Coulter D.A., Huguenard J.R., Prince D.A. Specific petit mal anticonvulsants reduce calcium currents thalamic neurons. Neuroscience Letters. 98:1989;74-78.
4. Cribbs L.L., Lee J.-H., Yang J., Satin J., Zhang Y., Daud A., Barclay J., Williamson M.P., Fox M., Rees M., Perez-Reyes E. Cloning and characterization of a1H from human heart, a member of the T-type calcium channel gene family. Circulation Research. 83:1998;103-109.
5. + channels, BW619C89, in rat middle cerebral artery occlusion. Journal of Pharmacology and Experimental Therapeutics. 269:1994;854-859.
6. Gutnick M.J., Yarom Y. Low threshold calcium spikes, intrinsic neuronal oscillation and rhythm generation in the CNS. Journal of Neuroscience Methods. 28:1989;93-99.
7. Hainsworth A.H., Marfia G.A., Centonze D., Leach M.J., Bernardi G., Calabresi P. The neuroprotective agent BW619C89 inhibits neuronal excitability and synaptic transmission in rat cortical slices. British Journal of Pharmacology. 126:1999;291P.
8. Huguenard J.R. Low-threshold calcium currents in central nervous system neurons. Annual Review of Physiology. 58:1996;329-348.
9. Huguenard J.R., Prince D.A. Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects. Journal of Neuroscience. 14:1994;5485-5502.
10. Leach M.J., Swan J.H., Eisenthal D., Dopson M., Nobbs M. BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke. 24:1993;1063-1067.
11. Lee J.-H., Daud A.N., Cribbs L.L., Lacerda A.E., Pereverzev A., Klöckner U., Schneider T., Perez-Reyes E. Cloning and expression of a novel member of the low-voltage activated T-type calcium channel family. Journal of Neuroscience. 19:1999;1912-1921.
12. Llinas R., Yarom Y. Electrophysiology of mammalian inferior olivary neurons in vitro. Different types of voltage-dependent ionic conductances. Journal of Physiology. 315:1981;549-567.
13. Macdonald R.L., Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia. 36:1995;S2-S12.
14. McCormick D.A., Bal T. Sleep and arousal: thalamocortical mechanisms. Annual Review of Neuroscience. 20:1997;185-215.
15. 2+ channel II: Activation by physiological patterns of activity. Neuropharmacology. 37:1998;67-81.
16. 2+ channels by the neuroprotective agent BW619C89. Neuropharmacology. 36:1997;1795-1798.
17. 2+ containing solutions. Neuropharmacology. 36:1997;895-915.
18. 2+ channel III: pH-dependent inhibition by a synthetic macrocyclic polyamine. Neuropharmacology. 38:1999;19-38.
19. Mittman S., Guo J., Emerick M.C., Agnew W.S. Structure and alternative splicing of the gene encoding alpha(1I), a human brain T calcium channel alpha(1) subunit. Neuroscience Letters. 269:1999;121-124.
20. Perez-Reyes E., Cribbs L.L., Daud A., Lacerda A.E., Barclay J., Williamson M.P., Fox M., Ress M., Lee J.-H. Molecular characterisation of a low-voltage-activated T-type calcium channel. Nature. 391:1998;896-900.
21. Puil E., Meiri H., Yarom Y. Resonant behaviour and frequency preferences of thalamic neurons. Journal of Neurophysiology. 71:1994;575-582.
22. 2+ channels. Molecular and Cellular Neuroscience. 14:1999;255-272.
23. Smith S.E., Lekieffre D., Sowinski P., Meldrum B.S. Cerebroprotective effect of BW619C89 after focal or global cerebral ischemia in the rat. Neuroreport. 4:1993;1339-1342.
24. Stefani A., Hainsworth A.H., Spadoni F., Bernadi G. On the inhibition of voltage-activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89. British Journal of Pharmacology. 125:1998;1058-1064.
25. 2+ currents in cortical neurons: functional implications. European Journal of Pharmacology. 307:1996;113-116.
26. Talley E.M., Cribbs L.L., Lee J.-H., Daud A., Perez-Reyes E., Bayliss D.A. Differential localisation of three members of a gene family encoding low voltage-activated (T-type) calcium channels. Journal of Neuroscience. 19:1999;1895-1911.
27. Tsakiridou E., Bertollini L., De Curtis M., Avanzini G., Pape H. Selective increase in T-type channel conductance in reticular thalamic neurons in a rat model of absence epilepsy. Journal of Neuroscience. 15:1995;3110-3117.
28. + channels. Neuroscience. 73:1996;951-962.
29. + channels in hippocampal neurones. Pflugers Archives. 430:1995;437-446.